The Oncology Institute, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$165M
↓-4.7% -$8Mvs FY2024
Total Liabilities
$180M
↑+6.7% +$11Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $165M | $173M |
| Current Assets | $113M | $112M |
| Cash | $0 | $0 |
| ST Investments | $0 | $0 |
| Receivables | $59M | $48M |
| Inventory | $17M | $10M |
| Other Current | $37M | $54M |
| Non-Current Assets | $52M | $60M |
| PPE | $11M | $12M |
| Goodwill | $7M | $7M |
| Intangibles | $11M | $15M |
| Investments | $0 | $0 |
| Other Non-Current | $23M | $26M |
| Total Liab+Eq | $165M | $173M |
| Current Liab. | $71M | $52M |
| Accounts Payable | $43M | $24M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $2M | $2M |
| Other CL | $26M | $26M |
| Non-Current Liab. | $109M | $117M |
| Long-Term Debt | $77M | $93M |
| Other LT Liab. | $32M | $24M |
| Equity | $-16M | $4M |
| Retained Earnings | $271M | $211M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · DFPH · Comparing FY2025 vs FY2024